Sell-Off in Strategy’s Preferred Stock Roils Investors
Strategy’s perpetual preferred stock has fallen from the $100 issuance price to the mid-$70s, prompting widespread in...
Participate in financial planning workshops tailored for young adults. Gain the skills needed to secure your financial future.
17,930 articlesStrategy’s perpetual preferred stock has fallen from the $100 issuance price to the mid-$70s, prompting widespread in...
Ethereum has long relied on DeFi as its power source. As staking and Layer 2s grow, the big question is whether ether...
A new survey finds a notable share of senior executives view data collection and use as ethically troubling, foreshad...
Meta Platforms is weighing a bold move into prediction markets, boosting investor interest and triggering a rally. An...
June payroll gains undershot forecasts, with revisions cooling prior months and participation slipping. The report le...
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
A sharp one-week move in a space stock can redefine risk and opportunity. This guide explains why rocket stock skyroc...
As the EV market accelerates, investors face a key question: which stock—Rivian or Tesla—fits their risk tolerance an...
The FDA has issued an urgent advisory to stop feeding infants Nara Organics infant formula after botulism cases were ...
Greg Abel, stepping into Warren Buffett's shoes, is quietly steering Berkshire Hathaway toward tech-driven bets. A bi...
Trump appears set to scrap the memorandum of understanding with Iran, yet U.S. markets are largely muted as traders f...
Moody's Analytics estimates the typical U.S. household has shouldered roughly $2,000 in costs tied to Iran-related sp...